Gustavo Denegri is an Italian businessman who has achieved success in multiple industries. After training as a chemist, he founded Gruppo Pro-Ind and merged it with Piaggio, a manufacturer of two-wheel vehicles. He grew Piaggio into a $1.2 billion company before selling his majority stake and moving to private equity. His biggest bet was DiaSorin, a biotech firm he acquired from Standard Companies in 2000. Today, DiaSorin is a global leader in in vitro diagnostics with revenue of over $500 million. In 2016, the U.S. Department of Health and Human Services awarded DiaSorin $2.6 million to develop a test for the Zika virus. Denegri's son Michele now runs Investimenti e Partecipazioni, a diverse portfolio of investments including medical technology, real estate, and TV production.
Gustavo Denegri is a member of Healthcare
